VYCEUM
Eli Lilly and Company
Mark For: VYCEUM™ trademark registration is intended to cover the categories of
| Website |
www.lilly.com
 |
| Research |
OneLook
Acronym Finder
|
| Serial Number | 90062733 |
| Mark Literal Elements | VYCEUM |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | TRADEMARK |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2021-02-02 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Bruce W. Longbottom |
Timeline
| 2020-07-20 | Application Filed |
| 2020-07-23 | Location: NEW APPLICATION PROCESSING |
| 2020-07-23 | Status: Live/Pending |
| 2020-07-23 | Transaction Date |
| 2020-12-08 | Published |
| 2021-02-02 | Location: INTENT TO USE SECTION |
| 2021-06-30 | Status: A first request for extension of time to file a Statement of Use has been granted. |
Trademark Parties (Applicants & Owners)
| Party: |  Eli Lilly and Company |
| Address | Lilly Corporate Center Indianapolis, INDIANA UNITED STATES 46285 |
| Legal Entity Type | Corporation |
| Legal Entity State | INDIANA |
Documents
 Application | MULTI | 2020-07-20 |
 Drawing | JPEG | 2020-07-20 |
| XSearch Search Summary | XML | 2020-11-03 |
| TRAM Snapshot of App at Pub for Oppostn | MULTI | 2020-11-06 |
| Notice of Publication | XML | 2020-11-18 |
| Notification Of Notice of Publication | XML | 2020-11-18 |
| OG Publication Confirmation | APPLICATION/XML | 2020-12-08 |
| Notice of Allowance | XML | 2021-02-02 |
| Extension of Time to File SOU | APPLICATION/XML | 2021-06-30 |
| ITU Extension Approval | APPLICATION/XML | 2021-07-02 |
| ITU Unit Action | MULTI | 2021-07-02 |
Attorney of Record
Good, Services, and Codes
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, osteoarthritis, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases; Diagnostic agents, preparations and substances for medical purposes; diagnostic scanning agents for medical use, namely, diagnostic scanning agents for in vivo use; radiopharmaceutical diagnostic preparations for medical use; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative amyloid diseases |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-07-02 | |
| TEAS EXTENSION RECEIVED | 2021-06-30 | |
| EXTENSION 1 GRANTED | 2021-06-30 | 98765 |
| EXTENSION 1 FILED | 2021-06-30 | 98765 |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2021-02-02 | |
| PUBLISHED FOR OPPOSITION | 2020-12-08 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-12-08 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2020-11-18 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2020-11-05 | |
| ASSIGNED TO EXAMINER | 2020-11-03 | 94051 |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-08-18 | |
| NEW APPLICATION ENTERED IN TRAM | 2020-07-23 |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 